Cargando…
In-silico design of a potential inhibitor of SARS-CoV-2 S protein
The SARS-CoV-2 virus has caused a pandemic and is public health emergency of international concern. As of now, no registered therapies are available for treatment of coronavirus infection. The viral infection depends on the attachment of spike (S) glycoprotein to human cell receptor angiotensin-conv...
Autores principales: | Jaiswal, Grijesh, Kumar, Veerendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529220/ https://www.ncbi.nlm.nih.gov/pubmed/33002032 http://dx.doi.org/10.1371/journal.pone.0240004 |
Ejemplares similares
-
Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach
por: Rolta, Rajan, et al.
Publicado: (2022) -
In Silico Evaluation of Cyclophilin Inhibitors as Potential Treatment for SARS-CoV-2
por: Laurie, Kyle, et al.
Publicado: (2021) -
In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors
por: Singh, Rahul, et al.
Publicado: (2021) -
Design, synthesis and in silico screening of benzoxazole–thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases
por: Krishna Cheerala, Vijay Sai, et al.
Publicado: (2021) -
In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis
por: Harisna, Azza Hanif, et al.
Publicado: (2021)